###begin article-title 0
###xml 28 32 <span type="species:ncbi:10090">Mice</span>
Targeted Deletion of p73 in Mice Reveals Its Role in T Cell Development and Lymphomagenesis
###end article-title 0
###begin p 1
Conceived and designed the experiments: OP. Performed the experiments: AN GP NN SiM OP. Analyzed the data: AN GP NN SiM OP. Contributed reagents/materials/analysis tools: NN SiM OP. Wrote the paper: OP.
###end p 1
###begin p 2
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 282 287 <span type="species:ncbi:10090">mouse</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
Transcriptional silencing of the p73 gene through methylation has been demonstrated in human leukemias and lymphomas. However, the role of p73 in the malignant process remains to be explored. We show here that p73 acts as a T cell-specific tumor suppressor in a genetically defined mouse model, and that concomitant ablation of p53 and p73 predisposes mice to an increased incidence of thymic lymphomas compared to the loss of p53 alone. Our results demonstrate a causal role for loss of p73 in progression of T cell lymphomas to the stage of aggressive, disseminated disease. We provide evidence that tumorigenesis in mice lacking p53 and p73 proceeds through mechanisms involving altered patterns of gene expression, defects in early T cell development, impaired apoptosis, and the ensuing accumulation of chromosomal aberrations. Collectively, our data imply that tumor suppressive properties of p73 are highly dependent on cellular context, wherein p73 plays a major role in T cell development and neoplasia.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 91 94 91 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Jost1">[1]</xref>
###xml 96 99 96 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Kaghad1">[2]</xref>
###xml 402 405 402 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Senoo1">[3]</xref>
###xml 407 410 407 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Talos1">[4]</xref>
###xml 565 568 565 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Melino1">[5]</xref>
###xml 722 725 722 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Corn1">[6]</xref>
###xml 726 729 726 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Gutierrez1">[8]</xref>
###xml 446 451 <span type="species:ncbi:9606">human</span>
###xml 660 665 <span type="species:ncbi:9606">human</span>
The p73 gene was identified as a structural p53 homologue and a potential tumor suppressor [1], [2]. However, in contrast to the established role of p53 in cancer prevention, a similar role of p73 in oncogenesis remains to be explored. Despite the purported ability of p73 to activate p53-responsive genes, p73-deficient cells do not display a proliferative advantage similar to that of p53-null cells [3], [4]. The p73 gene is rarely mutated in human cancers, and no compelling evidence exists that p73 inactivation is required for tumor initiation or progression [5]. Apart from subsets of acute lymphoblastic leukemia and non-Hodgkin's lymphomas, few other human tumor types inactivate p73 through epigenetic silencing [6]-[8].
###end p 4
###begin p 5
###xml 262 265 258 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Puig1">[9]</xref>
###xml 266 270 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Stiewe1">[11]</xref>
###xml 407 411 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Tomasini1">[12]</xref>
###xml 543 547 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Yang1">[13]</xref>
###xml 833 837 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Petrenko1">[14]</xref>
###xml 922 925 906 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Melino1">[5]</xref>
###xml 927 931 911 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Stiewe2">[15]</xref>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 908 913 <span type="species:ncbi:9606">human</span>
Unlike p53, the p73 gene locus gives rise to a complex pattern of isoforms with seemingly antagonistic properties. Many of the tumors upregulate the N-terminally truncated DeltaNp73 isoforms, often in conjunction with transactivation competent full-length TAp73 [9]-[11]. Targeted inactivation of TAp73 in mice produces a phenotype similar to that of p53+/- mice in terms of incidence and latency of tumors [12]. In contrast, Trp73 knockout mice (which lack all p73 isoforms) exhibit multiple developmental defects but no tumor predisposition [13]. These data imply that TAp73 may act as a tumor suppressor, while DeltaNp73 augments tumor development in vivo. In support, overexpression of DeltaNp73 promotes cellular immortalization and oncogenic transformation, albeit with low efficiency compared to p53 dominant-negative mutants [14]. Also, upregulation of DeltaNp73 is associated with poor prognosis in human cancers [5], [15].
###end p 5
###begin p 6
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Flores1">[16]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-PerezLosada1">[17]</xref>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Flores2">[18]</xref>
###xml 674 677 674 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Senoo1">[3]</xref>
###xml 827 830 827 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Talos1">[4]</xref>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
An open question is whether p73 contributes to p53-mediated tumor suppression. One recent study showed that mice heterozygous for both p53 and p73 display higher tumor burden and metastasis compared to p53+/- mice [16], suggesting that mutations affecting p53 and p73 have additive effects in vivo. However, this gene interaction appears to be tissue-specific, as in a separate study p53+/- and p53+/-p73+/- mice exhibited no differences in radiation-induced lymphomagenesis [17]. Likewise, it was suggested that p73 loss impairs p53-dependent apoptosis in response to DNA damage [18]. However, p73 was found to be dispensable for p53-dependent apoptosis of T cells in vivo [3]. Moreover, the poor transforming properties of p73-deficient MEFs were seen as a consequence of compensatory activation rather than weakening of p53 [4]. Here, we set out to clarify this functional p53-p73 interrelationship by analyzing spontaneous tumorigenesis in mice deficient for both p53 and p73. Our data imply that the tumor suppressive properties of p73 are highly dependent on cellular context, wherein p73 plays a major p53-dependent role in T cell development and neoplasia.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice Deficient in p53 and p73 Are Highly Prone to T Cell Lymphomas
###end title 8
###begin p 9
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Yang1">[13]</xref>
###xml 740 747 740 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1A</xref>
###xml 929 933 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Yang1">[13]</xref>
###xml 1087 1094 1087 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1A</xref>
###xml 1238 1245 1238 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1A</xref>
###xml 1354 1361 1354 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1B</xref>
###xml 1449 1456 1449 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1B</xref>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 1157 1161 <span type="species:ncbi:10090">mice</span>
###xml 1309 1313 <span type="species:ncbi:10090">mice</span>
###xml 1400 1404 <span type="species:ncbi:10090">mice</span>
It was originally discovered and reported that p73-null mice survive to birth, but then exhibit a high rate of postnatal mortality caused by extensive brain defects, gastrointestinal hemorrhages, chronic infections and inflammation [13]. Therefore, animal studies to evaluate the long-term effect of p73 deficiency on cancer development were rendered not feasible. However, contrary to the accepted view, we found that growth retardation and the reduced postnatal survival of p73-/- mice were mainly due to malnutrition caused by their inability to compete with WT and p73+/- littermates. Identifying such p73-/- pups at an early stage and housing them with foster lactating mothers rescued nearly 80% of the mice to adulthood (>1.5 years, Fig. 1A). Thus far, we generated large cohorts of mice deficient for p73 and/or p53 and monitored them for developmental defects and tumor predisposition. In agreement with previous report [13], p73-/- mice in our group exhibited partially penetrant congenital hydrocephalus, and 20% of them died at an early age from intraventricular hemorrhage (Fig. 1A). Likewise, 25% to 30% of p53+/-p73-/- and p53-/-p73-/- (DKO) mice exhibited a shortened longevity due to inherent neurodevelopmental defects (Fig. 1A). Importantly, however, none of the long-term surviving p73-/- mice developed clinical signs of malignancy (Fig. 1B), in contrast to p53+/-p73-/- and DKO mice which succumbed to tumors at a later stage (Fig. 1B).
###end p 9
###begin title 10
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient for p53 and p73 are highly prone to T cell lymphomas.
###end title 10
###begin p 11
###xml 0 5 0 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A, B.</bold>
###xml 38 39 38 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 66 67 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 166 168 166 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 259 261 259 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D.</bold>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
A, B. Kaplan-Meier curves of overall (A) and tumor-free survival (B) of p73-/-, p53+/-p73+/- and p53-/-p73-/- mice. The number of mice of each genotype is indicated. C. Kaplan-Meier curves of tumor-free survival of p53-/-, p53-/-p73+/- and p53-/-p73-/- mice. D. Tumor spectra in mice of the indicated genotypes.
###end p 11
###begin p 12
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Donehower1">[19]</xref>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Jacks1">[20]</xref>
###xml 206 213 206 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1C</xref>
###xml 324 331 324 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1C</xref>
###xml 529 536 529 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1C</xref>
###xml 900 907 900 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1D</xref>
###xml 912 919 912 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007784-t001">Table 1</xref>
###xml 1038 1045 1038 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1D</xref>
###xml 1050 1057 1050 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007784-t001">Table 1</xref>
###xml 1183 1190 1183 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007784-t001">Table 1</xref>
###xml 1573 1580 1573 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1D</xref>
###xml 1585 1592 1585 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007784-t001">Table 1</xref>
###xml 1774 1778 1774 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Donehower2">[21]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 1018 1022 <span type="species:ncbi:10090">mice</span>
###xml 1145 1149 <span type="species:ncbi:10090">mice</span>
###xml 1253 1257 <span type="species:ncbi:10090">mice</span>
###xml 1418 1422 <span type="species:ncbi:10090">mice</span>
###xml 1644 1648 <span type="species:ncbi:10090">mice</span>
###xml 1740 1744 <span type="species:ncbi:10090">mice</span>
Mice lacking p53 are developmentally normal but tumor-prone, sustaining high rates of thymic lymphomas and other tumors [19], [20]. Most p53-/- mice in our group also succumbed to tumors within 2-6 months (Fig. 1C, curve I). Loss of one p73 allele had no significant effect on overall survival in this experimental setting (Fig. 1C, curve II), while loss of both p73 alleles shortened the lifespan of p53-/- mice, with DKO animals exhibiting a mean survival of 3.54+/-0.9 months compared to 3.92+/-1.4 months of p53-/- controls (Fig. 1C, curve III). Although the differences in terms of survival were small, loss of even one p73 allele significantly altered the tumor phenotype of p53-null mice. Thus, p53-/- mice developed thymic lymphomas (66%), high-grade sarcomas (26%), B cell lymphomas (8%), as well as occasional adenocarcinomas (4%), teratocarcinomas (4%), mesothelioma, and medulloblastoma (Fig. 1D and Table 1). In contrast, thymic lymphomas accounted for 82% and 83% of tumors found in p53-/-p73+/- and DKO mice, respectively (Fig. 1D and Table 1), whereas B cell lymphomas, sarcomas and carcinomas were less frequent in p53-/-p73+/- mice and even less so in DKO animals (Table 1). The differences in tumor frequencies between p53-/- and DKO mice were statistically significant (p<0.00091 and 0.00055 for T cell lymphomas and solid tumors, respectively, by Kendall's W test). Only five of forty (12.5%) DKO mice had various types of sarcomas, while adenocarcinomas were not found in DKO animals by the time they were 5 months old and other tumor types occurred (Fig. 1D and Table 1). Other, less frequent tumor types observed in DKO mice included low grade intestinal adenomas (5%) and malignant teratomas (7.5%), to which 129Sv mice have a modest predisposition [21].
###end p 12
###begin title 13
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Tumor spectrum of p53-/- mice with zero, one, or two p73 alleles.
###end title 13
###begin p 14
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
The percentage of mice with tumors and the mean number of tumors per mouse are shown.
###end p 14
###begin p 15
NOS, not otherwise specified.
###end p 15
###begin title 16
Loss of p73 Enhances Dissemination of Lymphoma to Peripheral Organs
###end title 16
###begin p 17
###xml 139 145 139 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g002">Fig. 2</xref>
###xml 508 514 508 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g002">Fig. 2</xref>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 940 944 <span type="species:ncbi:10090">mice</span>
A characteristic feature of lymphomas arising in p53-/- mice is that they remain within the thymus and only rarely spread to other organs (Fig. 2). By contrast, many of the lymphomas arising in p53-/-p73+/- mice and virtually all thymic tumors developed by DKO animals acquired the capacity to infiltrate adjacent structures and the periphery. Massive lymphatic accumulations were observed in mediastinal lymph nodes, lungs, and, on more rare occasions, in heart, liver, and kidneys of the affected animals (Fig. 2). At the cellular level, lymphomas arising in p53-/-p73+/- and DKO mice were invariably immature CD4+CD8+ double positive cells with a significant proportion of CD8-single positive cells, but few mature CD4-single positive cells. Most of these tumors expressed variable amounts of CD3, some of them showing a mixture of CD3-positive and CD3-negative T cells (data not shown). In sum, combined loss of p53 and p73 predisposes mice to lymphoblastic T cell lymphomas with widespread dissemination to peripheral organs.
###end p 17
###begin title 18
Loss of p73 enhances dissemination of lymphoma to peripheral organs.
###end title 18
###begin p 19
###xml 120 124 120 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A, B</bold>
###xml 134 135 134 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 146 147 146 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 161 162 161 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 238 239 238 239 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 207 212 <span type="species:ncbi:10090">mouse</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
Hematoxylin and eosin staining of tissues from tumor-bearing p53-/-p73-/- mice showing lymphatic accumulation in lungs (A, B), liver (D), kidney (E), and heart (F). Lung section of a lymphoma-bearing p53-/- mouse is shown for comparison (C). Magnification 4X. The table lists the numbers of thymic lymphomas from mice with the indicated genotypes that either exhibited or lacked clear indications of invasion of peripheral organs by lymphoma.
###end p 19
###begin title 20
Loss of p73 Promotes T Cell Lymphomagenesis Independent of Age
###end title 20
###begin p 21
###xml 555 563 555 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007784.s001">Fig. S1A</xref>
###xml 664 671 664 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g003">Fig. 3A</xref>
###xml 761 768 761 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g003">Fig. 3B</xref>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 724 728 <span type="species:ncbi:10090">mice</span>
We considered a possibility that the high frequency of lymphomas in DKO mice as compared to p53-/- mice may be due to a block in T cell development caused by the loss of p73 function. Alternatively, it could result from phenotypic variations in age-related thymic involution. However, thymi of 4- to 12-week-old p73-/- and DKO mice showed a histologically normal architecture, with well defined cortical and medullary areas (data not shown). Furthermore, atrophy of the thymus, as measured by total T cell reduction, was unaffected by the absence of p73 (Fig. S1A). In contrast, the onset of lymphoma development was accelerated in both p53-/-p73+/- and DKO mice (Fig. 3A). Importantly, no lymphomas arising in p53-/-p73+/- mice displayed LOH at the p73 locus (Fig. 3B), thus indicating that not only the complete loss of p73 but also a reduction of its dosage suffices to promote T cell lymphomagenesis independent of age.
###end p 21
###begin title 22
Loss of p73 promotes T cell lymphomagenesis independent of age.
###end title 22
###begin p 23
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 83 85 83 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
A. The dynamics of T cell lymphoma development in mice of the indicated genotypes. B. LOH analysis at the p73 locus by genomic PCR of tumor tissues derived from p53-/-, p53+/-p73-/-, and p53-/-p73-/- (DKO) mice. Tumor numbers are indicated.
###end p 23
###begin p 24
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Attardi1">[22]</xref>
###xml 242 249 242 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g001">Fig. 1B</xref>
###xml 493 501 493 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007784.s001">Fig. S1B</xref>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
Thymic involution in p53+/- mice occurs before appreciable numbers of thymocytes lose the remaining p53 allele [22]. Therefore, p53 heterozygous mice acquire tumors at older age, most often osteosarcomas and soft tissue sarcomas. As shown in Fig. 1B, the presence of one p53 allele alleviated the effects of p73 deficiency on tumor formation. However, while the control p53+/- mice succumbed mainly to high-grade sarcomas, thymic lymphomas were the major tumor type seen in p53+/-p73-/- mice (Fig. S1B, C).
###end p 24
###begin title 25
Inactivation of p73 Causes Defects in T Cell Development
###end title 25
###begin p 26
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Blackburn1">[23]</xref>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
T cell development is characterized by the progression through several phenotypically distinct stages, defined as double negative (DN), double positive (DP), and single positive (SP), based on the expression of CD4 and CD8 markers. The DN thymocyte subset is further subdivided into four stages (DN1-4) by differential expression of CD25 and CD44 [23]. To determine whether p73 loss affects T cell development, lymphoid organs (bone marrow, thymi, spleens) of p73-/- and DKO mice were characterized by flow cytometry and PCR.
###end p 26
###begin p 27
###xml 75 82 75 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g004">Fig. 4A</xref>
###xml 236 243 236 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g004">Fig. 4B</xref>
###xml 347 354 347 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g004">Fig. 4C</xref>
###xml 456 463 456 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g004">Fig. 4D</xref>
###xml 571 581 571 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g004">Fig. 4E, F</xref>
###xml 734 741 734 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g004">Fig. 4C</xref>
###xml 1016 1020 1016 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Bassing1">[24]</xref>
###xml 1151 1154 1151 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Senoo1">[3]</xref>
###xml 1303 1310 1303 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g004">Fig. 4G</xref>
###xml 1405 1415 1405 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g004">Fig. 4E, F</xref>
###xml 1469 1476 1469 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g004">Fig. 4D</xref>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 1177 1181 <span type="species:ncbi:10090">mice</span>
The analysis revealed that p73 is expressed throughout T cell development (Fig. 4A). The frequency of primitive lymphoid progenitors (LSK) in bone marrow and early T lineage progenitors (ETP) in thymi of p73-/- and DKO mice was normal (Fig. 4B). The proportions of DP, CD4-SP and CD8-SP thymic subsets were also comparable with those of controls (Fig. 4C). However, the total number of thymocytes in p73-/- mice was only 70% that of wild-type littermates (Fig. 4D). Deletion of p73 caused a partial arrest at the DN2/DN3 stage and reduced the numbers of DN4 pro-T cells (Fig. 4E, F). DN2 and DN3 thymocytes that escaped this partial developmental arrest retained the ability to generate DN4 cells and undergo further differentiation (Fig. 4C). However, in isolated cases spleens of p73-/- mice were devoid of T cells (data not shown). In view that the generation of double strand breaks during V(D)J recombination poses a risk for genomic instability in DN2/DN3 and DP stage thymocytes and accumulation of mutations [24], we surmised that the DNA damage response and apoptosis might be disrupted upon combined inactivation of p53 and p73. As reported [3], thymocytes of p73-/- mice displayed only slightly reduced levels of apoptosis compared to WT controls, but it was lessened by the deletion of p53 (Fig. 4G). The developmental arrest imposed by p73 deficiency was also rescued by the deletion of p53 (Fig. 4E, F), restoring thymic cellularity to WT control levels (Fig. 4D).
###end p 27
###begin title 28
Inactivation of p73 causes defects in T cell development.
###end title 28
###begin p 29
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 288 290 288 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 586 588 586 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 741 743 741 743 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D.</bold>
###xml 906 911 906 911 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E, F.</bold>
###xml 1096 1097 1096 1097 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1140 1141 1140 1141 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1304 1306 1304 1306 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G.</bold>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 1366 1370 <span type="species:ncbi:10090">mice</span>
A. Semi-quantitative RT-PCR analysis of p73 mRNA levels in sorted bone marrow Lin-Sca1+c-Kit+ (LSK) cells, thymic CD4/CD8 double negative (DN), CD4/CD8 double positive (DP), CD4-SP and CD8-SP cells from WT mice. HPRT is a control for equal input. p73-/- thymocytes are shown for control. B. The frequency of LSK lymphoid progenitors in bone marrow and early T lineage progenitors (ETP) in thymi of mice of the indicated genotypes. ETP cells represent a c-Kit-positive subset of the DN1 (CD44+CD25-) population. The error bars represent the standard error obtained from six experiments. C. Relative numbers of DP, CD4-SP and CD8-SP T cell in thymi from 4-week old mice of the indicated genotypes. The error bars represent the standard error. D. Total cell numbers in thymi and spleens of 4 week-old mice of the indicated genotypes. The error bars represent the standard error obtained from six experiments. E, F. Thymocytes from 4-week old mice of the indicated genotypes were stained with antibodies to CD4, CD8, CD25 and CD44. Gating on CD4/CD8 double negative cells. Relative numbers of DN1-4 (E) and absolute numbers of DN3/DN4 subsets (F) are indicated. The error bars represent the standard error obtained from eight experiments. P-values for the difference between WT and p73-/- subsets are shown. G. Annexin V staining of DN and DP thymocytes from 4 week-old mice of the indicated genotypes. The error bars represent the standard error obtained from three experiments.
###end p 29
###begin p 30
###xml 459 466 445 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g005">Fig. 5A</xref>
###xml 532 540 518 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007784.s002">Fig. S2A</xref>
###xml 617 624 603 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g005">Fig. 5A</xref>
###xml 777 784 763 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g005">Fig. 5B</xref>
###xml 856 860 842 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Pals1">[25]</xref>
###xml 992 1002 968 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g005">Fig. 5B, C</xref>
###xml 1007 1015 983 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007784.s002">Fig. S2A</xref>
###xml 1194 1201 1170 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g005">Fig. 5B</xref>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
To explore whether the early T cell developmental program takes place correctly in thymocytes of p73-deficient mice, the expression of the genes involved in early cell-fate decisions and differentiation processes was examined by quantitative RT-PCR. In these experiments, mRNA levels of Bcl11b, Notch1, Notch3 and pre-TCR components (pTalpha, CD3delta, CD3epsilon) in DN thymocytes of p73-/- mice were markedly reduced compared with those of WT control mice (Fig. 5A), and this expression pattern was maintained until the DP stage (Fig. S2A-C). In contrast, p53 mRNA levels were increased twofold in p73-/- DN cells (Fig. 5A). Likewise, p73-deficient thymocytes contained altered mRNA levels of LFA-1 (integrin beta 2) and chemokine receptors CCR4, CCR7, CCR8, CCR9 and CXCR5 (Fig. 5B), which have been implicated in lymphocyte migration and dissemination [25]. Expression levels of pTalpha, CD3epsilon, CCR4, CCR7, CCR8, CCR9 and CXCR3 genes were also lower in DKO compared to p53-/- cells (Fig. 5B, C and Fig. S2A-C). Similarities between p53-/- and DKO DP thymocytes included conspicuously low mRNA levels of Notch1-3 and chemokine receptors CCR2, CCR4, CCR7, CCR8, CXCR3, CXCR5, and CXCR6 (Fig. 5B). Thus, loss of p73 synergizes with p53 loss-of-function in altering the developmental and/or migratory properties of immature T cells.
###end p 30
###begin title 31
Loss of p73 alters the expression pattern of genes involved in T cell development.
###end title 31
###begin p 32
###xml 0 4 0 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;C.</bold>
A-C. Quantitative RT-PCR analysis of genes encoding critical factors of T cell development in DN and DP thymocytes of the indicated genotypes. Each sample was analyzed in duplicate. mRNA expression levels were normalized to hypoxanthine-guanine phosphoribosyl transferase (HPRT) mRNA amount.
###end p 32
###begin title 33
Aneuploidy and Clonal Translocations Contribute to the Development of p73-Deficient Lymphomas
###end title 33
###begin p 34
###xml 137 144 130 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g006">Fig. 6A</xref>
###xml 212 219 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g006">Fig. 6B</xref>
###xml 396 400 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Lista1">[26]</xref>
###xml 402 406 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Kang1">[27]</xref>
###xml 758 762 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Sakata1">[28]</xref>
###xml 763 767 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Ohi1">[30]</xref>
###xml 860 867 846 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g006">Fig. 6A</xref>
###xml 934 941 920 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g006">Fig. 6B</xref>
###xml 1063 1073 1049 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g006">Fig. 6A, B</xref>
###xml 1216 1223 1202 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g006">Fig. 6C</xref>
###xml 1512 1513 1486 1487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1524 1525 1498 1499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1634 1635 1596 1597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1647 1654 1609 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007784-g004">Fig. 4D</xref>
###xml 1705 1706 1667 1668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 379 384 <span type="species:ncbi:10090">mouse</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1127 1131 <span type="species:ncbi:10090">mice</span>
###xml 1382 1386 <span type="species:ncbi:10090">mice</span>
###xml 1411 1415 <span type="species:ncbi:10090">mice</span>
###xml 1793 1797 <span type="species:ncbi:10090">mice</span>
###xml 1836 1840 <span type="species:ncbi:10090">mice</span>
At the genomic level, rearrangements involving TCRbeta and TCRgamma gene loci were detected in premalignant thymocytes of all genotypes (Fig. 6A), and in lymphomas derived from p53-/-, p53-/-p73+/- and DKO mice (Fig. 6B). In contrast, interchromosomal translocations between TCRgamma and TCRbeta loci that have been used routinely as predictors for large-scale translocations in mouse thymocytes [26], [27], were not present in cells of either genotype (data not shown). Evidence for aberrant V(D)J rearrangements in 73-deficient thymocytes was obtained by assaying for internal deletion at the Bcl11b and Notch1 loci, which both contain cryptic recombination signal sequences (RSS) that are accessible to Rag, and are frequently mutated in T cell lymphomas [28]-[30]. Deletions at the Bcl11b gene locus were present in premalignant p53-/- and DKO thymocytes (Fig. 6A) and in lymphomas derived from p53-/-, p53-/-p73+/- and DKO mice (Fig. 6B). On the other hand, deletions at the Notch1 locus were found in the respective lymphomas but not in premalignant cells (Fig. 6A, B). The frequency of Bcl11b gene rearrangements in DKO mice was estimated to be 2 to 5-fold higher than that in the respective p53-/- controls (Fig. 6C). PCR of serial dilutions showed that rearrangement of the Bcl11b gene could be reliably detected in 300 ng of thymocyte DNA derived from premalignant p53-/- mice and 150 ng DNA from DKO mice (data not shown). Considering that this amount of thymocyte DNA corresponds to approximately5x104 and 2.5x104 cell equivalents, respectively (Sakata et al., 2004), and the normal thymus is composed of approximately5x107 cells (see Fig. 4D), our results suggest the existence of at least 103 thymocytes with internal deletions in the Bcl11b gene in thymi of premalignant p53-/- mice and twice that number in thymi of DKO mice.
###end p 34
###begin title 35
V(D)J recombination poses a risk for genomic instability in thymocytes deficient for p53 and p73.
###end title 35
###begin p 36
###xml 0 5 0 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A, B.</bold>
###xml 131 132 131 132 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 209 210 209 210 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 371 373 364 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
A, B. Genomyc PCR analysis of internal deletion at the Bcl11b and Notch1 loci in thymocytes from WT, p53-/-, p73-/-, and DKO mice (A), and in lymphomas derived from p53-/-, p53-/-p73+/- and p53-/-p73-/- mice (B). Consistent data were obtained from three mice of each genotype. TCRbeta and TCRgamma gene rearrangements are shown for controls. Tumor numbers are indicated. C. Relative frequency of rearranged Bcl11b gene in thymocytes from WT, p53-/-, p73-/-, and DKO mice. The results are representative of six mice of each genotype. The error bars represent the standard error.
###end p 36
###begin p 37
###xml 540 547 540 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007784.s003">Fig. S3</xref>
###xml 668 675 668 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007784.s003">Fig. S3</xref>
###xml 914 921 914 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007784.s004">Fig. S4</xref>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
To examine chromosomal alterations associated with p53 and p73 deficiency in more detail, array-based comparative genomic hybridization (CGH) assays were performed on five primary tumors of each p73 genotype. The analysis revealed that p53-/-p73+/- and DKO lymphomas resembled p53-null tumors in terms of extensive numerical chromosomal aberrations. Whole chromosome gains of 4, 9, 11, 14, and 15 were common in all types of lymphomas, indicating that tumor development in a p53-null background favors the duplication of these chromosomes (Fig. S3). Distinct karyotypic events were also evident, as gains of chromosome 1 were more frequent in p73-deficient lymphomas (Fig. S3). Spectral karyotyping (SKY) of cell lines established from p53-/-p73+/- and DKO lymphomas revealed a modal chromosome number of 46-52 accompanied by several types of translocations, including t(8; 11), t(1; 10), t(13; 16), and t(16;17) (Fig. S4). Based on these data, we conclude that tumorigenesis in p53-/-p73+/- and DKO mice proceeds through mechanisms involving chromosome gains, losses, and clonal translocations. The contribution of numerical chromosomal changes is more than that of chromosomal translocations.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
We show here that p73 acts as a T cell-specific tumor suppressor in a genetically defined mouse model, and that concomitant ablation of p53 and p73 predisposes mice to an increased incidence of thymic tumors compared to the loss of p53 alone. Our results demonstrate a causal role for loss of p73 in progression of T cell lymphomas to the stage of aggressive, disseminated disease. We provide evidence that tumorigenesis in mice lacking p53 and p73 proceeds through mechanisms involving altered patterns of gene expression, defects in early T cell development at the immature DN2-DN4 stage, impaired apoptosis, and the ensuing accumulation of chromosomal aberrations, i.e. chromosome gains, losses, and clonal translocations. We further demonstrate that p73 loss alone cannot initiate tumorigenesis but it can cooperate with an initiating lesion, such as p53 loss-of-function, to make a premalignant cell tumorigenic and proliferatively aggressive. Based on the fact that B cell lymphomas, carcinomas and sarcomas occurred infrequently in p53-/-p73+/- mice and even less so in p53-/-p73-/- (DKO) animals, our data imply that tumor suppressive properties of p73 are highly dependent on cellular context, wherein p73 plays a major p53-dependent role in T cell development and neoplasia.
###end p 39
###begin p 40
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Bogue1">[31]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Haks1">[34]</xref>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Guidos1">[32]</xref>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Haks1">[34]</xref>
###xml 556 560 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Murga1">[35]</xref>
###xml 766 770 766 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Haines1">[36]</xref>
###xml 772 776 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Tsuji2">[37]</xref>
###xml 1267 1271 1257 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Sakata1">[28]</xref>
###xml 1273 1277 1263 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Osborne1">[38]</xref>
###xml 1279 1283 1269 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Wakabayashi1">[39]</xref>
###xml 1308 1311 1298 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Senoo1">[3]</xref>
###xml 2011 2015 2001 2005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Pals1">[25]</xref>
###xml 1320 1324 <span type="species:ncbi:10090">mice</span>
There are two current concepts of the cellular mechanisms responsible for the induction and maintenance of T cell lymphomas. One holds that p53 participates in a checkpoint response that eliminates DN thymocytes that do not display proper pre-TCR signaling. Cells that fail to express the pre-TCR exhibit developmental arrest at the DN3 stage, accompanied by massive apoptosis [31]-[34]. Ablation of p53 function can restore the survival of pre-TCR-deficient thymocytes, but at later time points these cells consistently give rise to lymphomas [32], [34], [35]. Another model holds that any genetic alteration leading to an early lymphocyte block and prolonged expression of Rag endonucleases can act as a procarcinogenic event, particularly in the p53 null setting [36], [37]. We present several lines of evidence to support a model in which disease acceleration as a direct or indirect consequence of p73 inactivation is caused by the alteration of expression patterns of genes involved in early cell-fate decisions, most notably pTalpha, CD3epsilon, Bcl11b, and Notch1. Accumulating evidence has highlighted the importance of these genes in the regulation of differentiation of lymphoid progenitor cells, the pre-TCR checkpoint and T cell-specific gene expression [28], [38], [39]. As previously reported [3], p73-/- mice produce a normal repertoire of mature T cells. However, we find that from a mechanistic perspective p73 deficiency perturbs early T cell development and thereby increases the number of T cell progenitors available for secondary mutations. While only a small percentage of such cells progress beyond the DN stage due to persistent p53-mediated cell cycle arrest and apoptosis, the deletion of p53 rescues this defect, but it comes at the expense of increased lymphomagenesis. Furthermore, p73-deficient thymocytes exhibit altered mRNA levels of chemokine receptors such as CCR4, CCR7, CCR8, CCR9, and CXCR3, which have been implicated in governing lymphocyte migration and dissemination [25].
###end p 40
###begin p 41
###xml 1152 1156 1152 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Sakata1">[28]</xref>
###xml 1158 1162 1158 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Haines1">[36]</xref>
###xml 1164 1168 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Tsuji2">[37]</xref>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
Our findings implicate Rag activity as an important contributing factor affecting lymphoma development in a p73-null background, while the loss of apoptosis through p53- and p73-deficiency allows accumulation of such genetic alterations. First, thymopoiesis in p73-/- mice is blocked at the DN3 stage that normally expresses Rag. Second, Rag-mediated internal deletions in the Bcl11b gene locus were detected in premalignant DKO thymocytes. We find that the frequency of Bcl11b gene deletions is twofold higher in premalignant DKO cells as compared with p53-null controls. Third, Rag-mediated internal deletions in the Notch1 locus were detected in DKO lymphomas, suggesting continuous Rag gene activity during the evolution of the transformed clones. In sum, although p53-/- and DKO lymphomas did not harbor Rag-mediated translocations of the TCR loci, our findings support a model in which persistent Rag expression contributes to tumorigenesis in an overall growth arrest-deficient and apoptosis-deficient p53-/-p73-/- null background. This model is consistent with previous reports that linked lymphomagenesis with Rag-mediated genomic alterations [28], [36], [37].
###end p 41
###begin p 42
###xml 714 717 714 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Corn1">[6]</xref>
###xml 718 721 718 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Gutierrez1">[8]</xref>
###xml 684 689 <span type="species:ncbi:9606">human</span>
###xml 839 845 <span type="species:ncbi:9606">humans</span>
The increased propensity to dissemination is a salient feature of p73-null lymphomas. We showed recently that p73 loss alters the clinical course of Myc-driven lymphomagenesis, characterized by a decreased tumor burden in lymphoid organs, but increased dissemination to extranodal sites (A Nemajerova and U Moll, submitted). Microarray analysis of p73-deficient lymphomas revealed a number of deregulated genes that encode proteins involved in cell adhesion and extracellular signaling. These data provide strong evidence that p73 loss alters gene expression patterns of various lineages. Because transcriptional silencing of the p73 gene through methylation has been demonstrated in human leukemias and lymphomas [6]-[8], it will be important to establish if p73 plays a similar role in regulation of T cell development and neoplasias in humans.
###end p 42
###begin title 43
Materials and Methods
###end title 43
###begin title 44
Ethics Statement
###end title 44
###begin p 45
All research involving animals has been conducted according to national and international guidelines with respect to husbandry, experimentation and welfare as part of this project. All animal studies were approved by the Institutional Animal Care and Use Committee at Stony Brook University.
###end p 45
###begin title 46
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and Flow Cytometry
###end title 46
###begin p 47
###xml 47 51 47 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Yang1">[13]</xref>
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Jacks1">[20]</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">Mice</span>
We used previously described p73-knockout mice [13] and p53-knockout mice [20]. All mice were housed in the maximum isolation facility. p53+/-p73+/- double heterozygous mice were derived by crossing between p73+/- and p53-/- animals, both on the 129S1/SvImJ background. p53-/-p73+/- mice were derived from crosses between the double heterozygous animals. p53-/-p73-/- mice (DKO) were derived from crosses between p53+/-p73+/- double heterozygous mice or p53+/-p73+/- and p53-/-p73+/- mice. The genotype of mice was verified by PCR amplification specific for the corresponding WT and mutant alleles. Mice were observed daily for precipitous changes in health and tumor development. Tumors that arose were harvested and processed for histological examination. Each tumor was fixed in formalin and sections were stained with hematoxylin and eosin. The extent of tumor dissemination was determined for at least 15 lymphomas of each genotype and graded the percentage of lung tissue invaded by lymphoma cells per 10X power field. Dissemination was classified into 4 grades: 0 = no signs of dissemination, 1 = minimal (<5% invaded tissue), 2 = moderate (up to 20% invaded tissue), 3 = strong (>30% invaded tissue). Lymphoid tissue samples were examined by flow cytometry with anti-CD3 (145-2C11), CD4 (H129.19 and GK1.5), CD8 (53-67), CD19 (MB19-1 and 1D3), CD25 (7D4), CD44 (IM7), B220 (CD45R) (RA3-6B2), TCRbeta (H57-597), TCRgamma (UC7-13D5), c-Kit (ACK2 and 2B8), and Sca1 (D7) antibodies (BD Pharmingen and eBiosacince). Kendall's coefficient of concordance, Wilcoxon matched pairs test, and Student's t-test were used in the statistical evaluation. For cell-cycle analysis, lymphoid cells were fixed in 70% ethanol, stained with propidium iodide and analyzed using FACS Calibur (Becton-Dickinson) with CellQuest software. Annexin V staining was performed as recommended by the manufacture (Roche).
###end p 47
###begin title 48
DNA and Expression Analyses
###end title 48
###begin p 49
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Cowell1">[40]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Nowak1">[41]</xref>
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Lista1">[26]</xref>
###xml 562 566 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Tsuji1">[29]</xref>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007784-Sakata1">[28]</xref>
###xml 1015 1023 1015 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007784.s005">Table S1</xref>
###xml 1150 1158 1146 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;CT</sup>
###xml 517 522 <span type="species:ncbi:10090">mouse</span>
Comparative genomic hybridization (CGH) and Spectral karyotyping (SKY) were performed at the Roswell Park Cancer Institute following published procedures [40], [41]. For SKY analysis, metaphase chromosomes were prepared from tumor cell lines at early-passage numbers. Ten to twenty metaphases were analyzed for each tumor. To assay for recombinations within and between TCRG and TCRB loci, nested PCR was performed as described previously [26]. Deletions between breakpoint regions at positions 4926 and 16674 of the mouse Notch1 gene were examined as described [29]. To assay for Bcl11b internal deletions, nested PCR was performed using primers homologous to the major breakpoint regions within introns 1 and 3 [28]. The identities of amplified PCR fragments were confirmed by DNA sequencing. Semiquantitative and Real-Time RT-PCR analyses were performed using whole cell RNAs prepared from primary lymphoid cells or tumors and previously described oligonucleotide primers. The sequences of primers are listed in Table S1. Relative expression of the target genes was calculated using the DeltaCT method described previously: Relative expression = 2-DeltaCT, where DeltaCT = CT (Target gene) - CT (HPRT).
###end p 49
###begin title 50
Supporting Information
###end title 50
###begin p 51
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
A. Total cell numbers in thymi of ageing mice of the indicated genotypes. The error bars represent the standard error obtained from three experiments. B. Kaplan-Meier curves of tumor-free survival of p53+/- and p53+/-p73-/- mice. The number of mice of each genotype is indicated. C. Tumor spectra in mice of the indicated genotypes.
###end p 51
###begin p 52
(0.57 MB TIF)
###end p 52
###begin p 53
Click here for additional data file.
###end p 53
###begin p 54
Quantitative RT-PCR analysis of genes encoding critical factors of T cell development in DN (A) or DP thymocytes (B, C) of the indicated genotypes. Each sample was analyzed in duplicate. mRNA expression levels were normalized to hypoxanthine-guanine phosphoribosyl transferase (HPRT) mRNA amount.
###end p 54
###begin p 55
(0.06 MB PDF)
###end p 55
###begin p 56
Click here for additional data file.
###end p 56
###begin p 57
###xml 109 113 <span type="species:ncbi:10090">mice</span>
CGH analysis of chromosomal alterations in primary T cell lymphomas from p53-/-, p53-p73+/- and p53-/-p73-/- mice. The results are representative of five tumors of each genotype. Chromosomal gains are shown in green, while chromosomal losses are shown in red. The blue boxes indicate the most common chromosomal aberrations.
###end p 57
###begin p 58
(1.25 MB TIF)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin p 60
SKY analysis of cell lines established from p53-/-, p53-p73+/- and p53-/-p73-/- T cell lymphomas. Chromosomes with numerical changes (white circles) and translocations (yellow circles) are indicated.
###end p 60
###begin p 61
(2.99 MB TIF)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
Primers for quantitative RT-PCR.
###end p 63
###begin p 64
(0.04 MB DOC)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
The authors would like to thank Ute M. Moll and Natalia Petrenko for their support and careful reading of the manuscript.
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
###xml 31 36 <span type="species:ncbi:9606">human</span>
p73 is a simian [correction of human] p53-related protein that can induce apoptosis.
###end article-title 68
###begin article-title 69
###xml 110 115 <span type="species:ncbi:9606">human</span>
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.
###end article-title 69
###begin article-title 70
p63 and p73 are not required for the development and p53-dependent apoptosis of T cells.
###end article-title 70
###begin article-title 71
p73 Suppresses Polyploidy and Aneuploidy in the Absence of Functional p53.
###end article-title 71
###begin article-title 72
p73: Friend or foe in tumorigenesis.
###end article-title 72
###begin article-title 73
Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.
###end article-title 73
###begin article-title 74
Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas.
###end article-title 74
###begin article-title 75
Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup.
###end article-title 75
###begin article-title 76
###xml 18 23 <span type="species:ncbi:9606">human</span>
p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer.
###end article-title 76
###begin article-title 77
Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
###end article-title 77
###begin article-title 78
Quantitative TP73 transcript analysis in hepatocellular carcinomas.
###end article-title 78
###begin article-title 79
TAp73 knockout shows genomic instability with infertility and tumor suppressor functions.
###end article-title 79
###begin article-title 80
###xml 14 18 <span type="species:ncbi:10090">mice</span>
p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.
###end article-title 80
###begin article-title 81
deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
###end article-title 81
###begin article-title 82
The p53 family in differentiation and tumorigenesis.
###end article-title 82
###begin article-title 83
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
###end article-title 83
###begin article-title 84
p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.
###end article-title 84
###begin article-title 85
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.
###end article-title 85
###begin article-title 86
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
###end article-title 86
###begin article-title 87
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Tumor spectrum analysis in p53-mutant mice.
###end article-title 87
###begin article-title 88
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Effects of genetic background on tumorigenesis in p53-deficient mice.
###end article-title 88
###begin article-title 89
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
Probing p53 biological functions through the use of genetically engineered mouse models.
###end article-title 89
###begin article-title 90
Developing a new paradigm for thymus organogenesis.
###end article-title 90
###begin article-title 91
The mechanism and regulation of chromosomal V(D)J recombination.
###end article-title 91
###begin article-title 92
Lymphoma dissemination: the other face of lymphocyte homing.
###end article-title 92
###begin article-title 93
###xml 150 156 <span type="species:ncbi:10090">murine</span>
The absolute number of trans-rearrangements between the TCRG and TCRB loci is predictive of lymphoma risk: a severe combined immune deficiency (SCID) murine model.
###end article-title 93
###begin article-title 94
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair.
###end article-title 94
###begin article-title 95
###xml 182 187 <span type="species:ncbi:10090">mouse</span>
Involvement of V(D)J recombinase in the generation of intragenic deletions in the Rit1/Bcl11b tumor suppressor gene in gamma-ray-induced thymic lymphomas and in normal thymus of the mouse.
###end article-title 95
###begin article-title 96
###xml 163 168 <span type="species:ncbi:10090">mouse</span>
Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
###end article-title 96
###begin article-title 97
Multi-step lymphomagenesis deduced from DNA changes in thymic lymphomas and atrophic thymuses at various times after gamma-irradiation.
###end article-title 97
###begin article-title 98
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes.
###end article-title 98
###begin article-title 99
V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors.
###end article-title 99
###begin article-title 100
Mutations in the p53 and SCID genes cooperate in tumorigenesis.
###end article-title 100
###begin article-title 101
Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells.
###end article-title 101
###begin article-title 102
Molecular mechanisms of pre-T cell receptor-induced survival.
###end article-title 102
###begin article-title 103
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.
###end article-title 103
###begin article-title 104
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Rag-dependent and Rag-independent mechanisms of Notch1 rearrangement in thymic lymphomas of Atm(-/-) and scid mice.
###end article-title 104
###begin article-title 105
Notch signalling during peripheral T-cell activation and differentiation.
###end article-title 105
###begin article-title 106
Bcl11b is required for differentiation and survival of alphabeta T lymphocytes.
###end article-title 106
###begin article-title 107
Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme.
###end article-title 107
###begin article-title 108
Challenges in array comparative genomic hybridization for the analysis of cancer samples.
###end article-title 108
###begin p 109
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 109
###begin p 110
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by the Carol M. Baldwin Breast Cancer Research award to O.P. A.N. was supported by a Fellowship from The Lymphoma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 110

